DNTH

DNTH Earnings Preview

Dianthus Therapeutics, Inc. · Healthcare · $5B

14d until earnings

DNTH Earnings

Monday, May 11 2026
EPS Estimate
$-1.10
$-1.56 – $-0.63
Revenue Estimate
$0M
Current Price
$87.39

Data Signal Summary

0 bullish
3 bearish
Insider selling cluster Put/call 1.7 (bearish skew) Price downtrend

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
-8.7%
Est. Revisions (30d)
+0.0% 2up/1dn
Analyst Target (mean)
$125 $98–$200 +44%
Options P/C Ratio
1.74
Est. Dispersion
84% 7 analysts
Insider Cluster
strong sell
Fund Convergence
strong D.E. Shaw, Citadel, Renaissance, Two Sigma

Recent Activity

insider trades 21 transactions
Sell · SAVITZ RYAN (Chief Financial Officer) ·8,224 shares ·$738,844
Exercise · SAVITZ RYAN (Chief Financial Officer) ·8,224 shares ·$147,045
Sell · SOTEROPOULOS PAULA (Director) ·599 shares ·$47,986
Exercise · SOTEROPOULOS PAULA (Director) ·599 shares ·$5,056
Sell · SAVITZ RYAN (Chief Financial Officer) ·114,367 shares ·$9,492,596
16 more
Exercise · SAVITZ RYAN ·114,367 shr ·$1,342,857
Sell · SOTEROPOULOS PAULA ·27,594 shr ·$2,153,712
Exercise · SOTEROPOULOS PAULA ·27,594 shr ·$232,893
Exercise · GARCIA MARINO ·65,292 shr ·$499,975
Sell · CARR EDWARD ·43,682 shr ·$3,559,495
Exercise · CARR EDWARD ·43,682 shr ·$893,259
Sell · GARCIA MARINO ·122,918 shr ·$10,016,381
Exercise · GARCIA MARINO ·122,918 shr ·$823,551
Sell · RANDHAWA SIMRAT ·33,830 shr ·$2,756,468
Exercise · RANDHAWA SIMRAT ·33,830 shr ·$614,166
Sell · SAVITZ RYAN ·20,000 shr ·$903,600
Exercise · SAVITZ RYAN ·20,000 shr ·$168,800
Sell · RANDHAWA SIMRAT ·196,538 shr ·$7,379,887
Exercise · RANDHAWA SIMRAT ·196,538 shr ·$2,998,136
Sell · SAVITZ RYAN ·20,000 shr ·$700,000
Exercise · SAVITZ RYAN ·20,000 shr ·$168,800